Shuaib Abdullah
Internal Medicine · Dallas, TXNPI 1770679334
Payments from drug & device makers
Across 202 payments — averaging $4985.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Operations, Inc.$408K
- CSL Behring$191K
- Merck$170K
- American Regent$82K
- Amgen$60K
- Pfizer$35K
- plus $60K from 7 others
What the payments were for
- Food & beverage$115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Operations, Inc. | 59 | $408,347 |
| CSL Behring | 81 | $191,291 |
| Merck | 22 | $169,622 |
| American Regent | 10 | $82,461 |
| Amgen | 11 | $59,999 |
| Pfizer | 7 | $35,151 |
| Boehringer Ingelheim International GmbH | 4 | $29,654 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $19,518 |
| Organon | 1 | $11,000 |
| Bracco Diagnostics Inc. | 2 | $47 |
| Johnson & Johnson | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Cvrx, Inc. | 1 | $20 |
How this compares
$1,007,157 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Dallas
- Amit VermaDallas$7.7M
- Valentine EbuhDallas$6.8M
- Gary SinclairDallas$3.4M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.